CONFERENCE COMMITTEE REPORT NO. 44

                            Honolulu, Hawaii
                                            , 1999

                            RE:   S.B. No. 1160
                                  S.D. 2
                                  H.D. 2
                                  C.D. 1




Honorable Norman Mizuguchi
President of the Senate
Twentieth State Legislature
Regular Session of 1999
State of Hawaii

Honorable Calvin K.Y. Say
Speaker, House of Representatives
Twentieth State Legislature
Regular Session of 1999
State of Hawaii

Sir:

     Your Committee on Conference on the disagreeing vote of the
Senate to the amendments proposed by the House of Representatives
in S.B. No. 1160, S.D. 2, H.D. 2, entitled:  

     "A BILL FOR AN ACT RELATING TO CONTROLLED SUBSTANCES," 

having met, and after full and free discussion, has agreed to
recommend and does recommend to the respective Houses the final
passage of this bill in an amended form.

     The purpose of this measure is to update and strengthen
Hawaii's drug laws by conforming the State Uniform Controlled
Substances Act to reflect changes in federal and State law.  Key
changes to the law effected by this measure include increasing
and broadening recordkeeping and reporting requirements,
standardizing the paper size requirements for prescriptions,
establishing that communications made to a physician for the
purpose of unlawfully procuring controlled substances are not
privileged physician-patient communications, and expanding the
penalty provisions. 


 
a                                                     SB1160 CD1
 
                            CONFERENCE COMMITTEE REPORT NO. 44
                            Page 2



     Upon careful consideration, your Committee on Conference has
amended this measure to:

     (1)  Make the theft, loss, and discrepancy reporting
          requirement of section 329-66, Hawaii Revised Statutes
          (HRS), applicable to all controlled substance
          transactions regulated under chapter 329, HRS; 

     (2)  Establish as one of the criteria for dietary
          supplements exempt from certain requirements of chapter
          329, HRS, the requirement that the supplement's
          labeling not recommend a daily intake of more than one
          hundred milligrams of ephedrine alkaloids; and 

     (3)  Exclude from the penalty provision transactions
          involving claims that the consumption of ephedrine
          products will result in heightened awareness and
          increased energy.

     Your Committee on Conference is in accord with the intent
and purpose of S.B. No. 1160, S.D. 2, H.D. 2, as amended herein,
and recommends that it pass Final Reading in the form attached
hereto as S.B. No. 1160, S.D. 2, H.D. 2, C.D. 1.

                                   Respectfully submitted,

MANAGERS ON THE PART OF THE        MANAGERS ON THE PART OF THE
            HOUSE                             SENATE
                                   
                                   
                                   
______________________________     ______________________________
ERIC G. HAMAKAWA, Co-Chair         BRIAN T. TANIGUCHI, Co-Chair
                                   
                                   
                                   
______________________________     ______________________________
SCOTT K. SAIKI, Co-Chair           BRIAN KANNO, Co-Chair
                                   
                                   
                                   
______________________________     ______________________________
SYLVIA J. LUKE, Member             SUZANNE CHUN OAKLAND, Co-Chair
                                   
                                   
                                   
______________________________     ______________________________
PAUL T. OSHIRO, Member             AVERY B. CHUMBLEY, Co-Chair

 
a                                                     SB1160 CD1
                            CONFERENCE COMMITTEE REPORT NO. 44
                            Page 3



                                   
                                   
                                   
______________________________     ______________________________
PAUL WHALEN, Member                SAM SLOM, Member

 
a                                                     SB1160 CD1